Incyte Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
Portfolio Pulse from Benzinga Insights
In the past three months, 8 analysts have provided diverse ratings for Incyte (NASDAQ:INCY), with a mix of bullish and indifferent perspectives. The average 12-month price target is $73.12, slightly down from the previous $73.83. Analysts' actions include maintaining, raising, and lowering ratings and price targets, reflecting their response to Incyte's market performance and developments. Incyte's financial performance shows a revenue growth of 9.35% but below industry benchmarks in net margin, ROE, and ROA, indicating challenges in profitability and asset utilization.
March 12, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Incyte has received mixed ratings from analysts, with an average 12-month price target of $73.12, indicating a slight decrease from the previous target. The company's financial performance shows significant revenue growth but faces challenges in profitability and asset utilization.
The mixed analyst ratings and slight decrease in the average price target suggest a neutral short-term impact on INCY's stock price. The company's revenue growth is positive, but challenges in profitability and asset utilization may temper investor enthusiasm.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100